12th week of 2022 patent applcation highlights part 10 |
Patent application number | Title | Published |
20220087993 | USE OF MIGALOSTAT IN REDUCING THE RISK OF CEREBROVASCULAR EVENT IN PATIENTS WITH FABRY DISEASE | 2022-03-24 |
20220087994 | HIGH LOAD DISPERSIONS AND USES THEREOF | 2022-03-24 |
20220087995 | 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS | 2022-03-24 |
20220087996 | Histone acetylase p300 inhibitor and use thereof | 2022-03-24 |
20220087997 | Oral Antagonist Compositions For Nicotine Burning Relief | 2022-03-24 |
20220087999 | C-Met Modulator Pharmaceutical Compositions | 2022-03-24 |
20220088000 | COMBINATION THERAPY | 2022-03-24 |
20220088001 | Method and System for Reducing the Likelihood of a Porphyromonas Gingivalis Infection in a Human Being | 2022-03-24 |
20220088002 | METHOD AGAINST CORONAVIRUS INFECTION WITH QUINOLINE COMPOUND | 2022-03-24 |
20220088003 | SMALL MOLECULE PROMOTING OSTEOBLAST DIFFERENTIATION | 2022-03-24 |
20220088004 | COMPOSITION FOR COMPETITIVE INHIBITION OF OREXIN RECEPTORS | 2022-03-24 |
20220088005 | BROMODOMAIN INHIBITORS FOR ANDROGEN RECEPTOR-DRIVEN CANCERS | 2022-03-24 |
20220088006 | ANALOGS OF DEUTETRABENAZINE, THEIR PREPARATION AND USE | 2022-03-24 |
20220088007 | Increasing Drug Bioavailability In Naltrexone Therapy | 2022-03-24 |
20220088008 | AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2022-03-24 |
20220088009 | ARIPIPRAZOLE ORAL SOLUBLE FILM | 2022-03-24 |
20220088010 | Co-Administration of inhibitors to produce insulin producing gut cells | 2022-03-24 |
20220088011 | THERAPEUTIC AGENT FOR A TUMOR COMPRISING AN IDO INHIBITOR ADMINISTERED IN COMBINATION WITH AN ANTIBODY | 2022-03-24 |
20220088012 | COMBINATION THERAPY | 2022-03-24 |
20220088013 | Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor | 2022-03-24 |
20220088014 | METHODS OF TREATING ADDICTION | 2022-03-24 |
20220088015 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES | 2022-03-24 |
20220088016 | CANCER TREATMENT USING MULTI-TARGETED KINASE INHIBITOR IN COMBINATION OF PROTEIN KINASE BIOMARKERS | 2022-03-24 |
20220088017 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | 2022-03-24 |
20220088018 | METALLOENZYME INHIBITOR COMPOUNDS | 2022-03-24 |
20220088019 | PAC-1 COMBINATION THERAPY | 2022-03-24 |
20220088020 | TREATMENT OF ALOPECIA AREATA | 2022-03-24 |
20220088021 | METHODS OF DIAGNOSING AND TREATING CANCER | 2022-03-24 |
20220088022 | THERAPEUTIC REGIMEN | 2022-03-24 |
20220088023 | ANTIDIABETIC MEDICATIONS | 2022-03-24 |
20220088024 | METHODS FOR TREATING CANCER USING TOZADENANT | 2022-03-24 |
20220088025 | FUSED THIOPHENE COMPOUNDS | 2022-03-24 |
20220088026 | METHODS OF TREATING TYROSINE KINASE INHIBITOR-INDUCED DIARRHEA | 2022-03-24 |
20220088027 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2022-03-24 |
20220088028 | NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONISTS AS THERAPEUTICS FOR CHRONIC TINNITUS | 2022-03-24 |
20220088029 | COMBINATION THERAPY OF TETRACYCLIC QUINOLONE ANALOGS FOR TREATING CANCER | 2022-03-24 |
20220088030 | METHODS FOR TREATMENT OF DISEASES | 2022-03-24 |
20220088031 | METHODS AND COMPOSITIONS FOR TREATING RESISTANT AND RECURRENT FORMS OF CANCER | 2022-03-24 |
20220088032 | COMPOSITIONS AND USES THEREOF FOR TREATMENT OF IDIOPATHIC PRETERM BIRTH | 2022-03-24 |
20220088033 | METHODS FOR TREATING OR PREVENTING CANCER IN A KRAS-VARIANT PATIENT AND FOR DIAGNOSING RISK OF DEVELOPING MULTIPLE PRIMARY BREAST TUMORS | 2022-03-24 |
20220088034 | METHODS OF TREATING TESTOSTERONE DEFICIENCY | 2022-03-24 |
20220088035 | PHARMACEUTICAL FORMULATIONS AND SYSTEMS FOR DELIVERY OF AN ANDROGENIC AGENT AND AN AROMATASE INHIBITOR AND METHODS FOR USE | 2022-03-24 |
20220088036 | CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A INHIBITORS | 2022-03-24 |
20220088037 | A SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE | 2022-03-24 |
20220088038 | METHOD FOR REDUCING FAT BY ADMINISTERING BENZENESULFONAMIDE COMPOSITIONS | 2022-03-24 |
20220088039 | METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS | 2022-03-24 |
20220088040 | Use of System XC-Inhibitor for Treating Statin-Induced Myalgia | 2022-03-24 |
20220088041 | METHOD FOR TREATING ANXIETY DISORDERS, HEADACHE DISORDERS, AND EATING DISORDERS WITH PSILOCYBIN | 2022-03-24 |
20220088042 | COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER | 2022-03-24 |
20220088043 | METHOD FOR TREATING CANCER USING A COMBINATION OF DNA-DAMAGING AGENTS AND DNA-PK INHIBITORS | 2022-03-24 |
20220088044 | SUBSTANCES FOR TREATMENT OF CORONAVIRUS INFECTION | 2022-03-24 |
20220088045 | Treatment compositions | 2022-03-24 |
20220088046 | VIRAL RECEPTOR BOUND WITH SIALIC ACID COMPOUNDS | 2022-03-24 |
20220088047 | METHOD FOR TREATING DUPUYTREN'S DISEASE | 2022-03-24 |
20220088048 | USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2022-03-24 |
20220088049 | COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES | 2022-03-24 |
20220088050 | TREATMENT OF FATTY LIVER DISEASE | 2022-03-24 |
20220088051 | DOUBLE-STRANDED OLIGONUCLEOTIDE TARGETING DKK1 GENE, CONSTRUCT INCLUDING SAME, AND HAIR LOSS PREVENTION OR HAIR GROWTH COMPOSITION CONTAINING SAME | 2022-03-24 |
20220088052 | TFAP2 INHIBITION FOR TREATING CARDIAC DISEASE INVOLVING FIBRO-FATTY REPLACEMENT | 2022-03-24 |
20220088053 | Usb1 Directed Regulation Of Mirnas Related Hematopoietic Differentiation And Affected In Multiple Forms Of Leukemia | 2022-03-24 |
20220088054 | IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT | 2022-03-24 |
20220088055 | Medicinal composition comprising a non-coding RNA molecule and an antibody targeting a tumor antigen | 2022-03-24 |
20220088056 | COMBINATION FOR TREATING CANCER | 2022-03-24 |
20220088057 | THERAPEUTIC AGENT FOR FIBROSIS | 2022-03-24 |
20220088058 | ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME | 2022-03-24 |
20220088059 | COMBINED SPHERICAL NUCLEIC ACID AND CHECKPOINT INHIBITOR FOR ANTITUMOR THERAPY | 2022-03-24 |
20220088060 | NAIL COMPOSITIONS HAVING ANTIFUNGAL PROPERTIES | 2022-03-24 |
20220088061 | COSMETIC/DERMATOLOGICAL COMPOSITION | 2022-03-24 |
20220088062 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | 2022-03-24 |
20220088063 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | 2022-03-24 |
20220088064 | DRUG AND PRODUCTION METHOD THEREFOR | 2022-03-24 |
20220088065 | Inorganic Nitrite to Improve Cardiopulmonary Hemodynamics | 2022-03-24 |
20220088066 | A STABLE CARDIOPLEGIC SOLUTION FOR CARDIAC SURGERY | 2022-03-24 |
20220088067 | PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES | 2022-03-24 |
20220088068 | CATALYTIC SYSTEMS INCLUDING A PEROXIDE FOR DELIVERY OF OXYGEN TO SKIN AND RELATED METHODS OF USE | 2022-03-24 |
20220088069 | TREATMENT OF NSCLC PATIENTS REFRACTORY FOR ANTI-PD-1 ANTIBODY | 2022-03-24 |
20220088070 | METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY | 2022-03-24 |
20220088071 | A BW6 Specific CAR Designed To Protect Transplanted Tissue From Rejection | 2022-03-24 |
20220088072 | TREATMENT METHOD FOR PSORIASIS | 2022-03-24 |
20220088073 | CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED TUMOR INFILTRATION | 2022-03-24 |
20220088074 | GENETICALLY MODIFIED GAMMA DELTA T CELLS AND METHODS OF MAKING AND USING | 2022-03-24 |
20220088075 | COMBINATION THERAPIES OF EGFRVIII CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS | 2022-03-24 |
20220088076 | Therapeutic Cell Systems and Methods for Treating Cancer and Infectious Diseases | 2022-03-24 |
20220088077 | GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE | 2022-03-24 |
20220088078 | GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE | 2022-03-24 |
20220088080 | RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES | 2022-03-24 |
20220088081 | RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES | 2022-03-24 |
20220088082 | Compositions and Method for Treating Primary Sclerosing Cholangitis and Related Disorders | 2022-03-24 |
20220088083 | COMPOSITION FOR USE IN TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA | 2022-03-24 |
20220088084 | USES OF MESENCHYMAL STEM CELLS | 2022-03-24 |
20220088085 | COMPOSITION FOR TREATING BLOOD COAGULATION AND/OR COMPLEMENT DISORDERS | 2022-03-24 |
20220088087 | PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION | 2022-03-24 |
20220088088 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2022-03-24 |
20220088089 | METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS | 2022-03-24 |
20220088090 | MICROBIOME RELATED IMMUNOTHERAPIES | 2022-03-24 |
20220088091 | SYNBIOTIC COMPOSITIONS | 2022-03-24 |
20220088092 | COMPOSITIONS AND METHODS FOR INCREASING THE VIABILITY OF FREEZE-DRIED PROBIOTICS | 2022-03-24 |
20220088093 | Novel Lactobacillus Having Various Functions, and Use Thereof | 2022-03-24 |
20220088094 | PROBIOTIC COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI STRAINS AND METHODS OF USE | 2022-03-24 |
20220088095 | METHOD FOR REGULATING EXPRESSION OF IL-1b GENE, MMP1a GENE AND TIMP1 GENE OF CHONDROCYTES USING LACTOBACILLUS PLANTARUM STRAIN TCI227 | 2022-03-24 |